TD Cowen Reiterates Buy on Surgery Partners, Maintains $19 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.8%

Neg 0% Neu 87.8% Pos 0%

TD Cowen analyst Ryan Langston reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $19 price target.

Comments

No comments yet. Be the first!